Evidence map›Paper›PMID 33426503›Full record

ArticleJournal of translational genetics and genomics2020

Redefining infantile-onset multisystem phenotypes of coenzyme Q

Andres Berardo, Catarina M Quinzii

Open access · diamondAbstract read
In one paragraph

Article in Journal of translational genetics and genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. The efficacy of coenzyme QJournal of cellular and molecular medicine · 2022
    Pooled it
  2. Article
  3. Identification of a newMolecular genetics and metabolism reports · 2025
    Article
  4. Understanding coenzyme Q.Physiological reviews · 2024
    Review
  5. COQ7 defect causes prenatal onset of mitochondrial CoQEuropean journal of human genetics : EJHG · 2024
    Article
  6. Article
  7. Biosynthesis, Deficiency, and Supplementation of Coenzyme Q.Antioxidants (Basel, Switzerland) · 2023
    Review
  8. A novelMolecular genetics and metabolism reports · 2022
    Article
  9. Cellular Models for Primary CoQ Deficiency Pathogenesis Study.International journal of molecular sciences · 2021
    Review
  10. Role of Coenzyme QAntioxidants (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andres BerardoDepartment of Neurology, Columbia University Medical Center, New York, NY 10032, USA.
Catarina M QuinziiDepartment of Neurology, Columbia University Medical Center, New York, NY 10032, USA.
Columbia University Irving Medical Center · US

Funding

Tech-CoreP01HD080642 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI QUINZII, CATARINA M. · 2014 to 2018
$7.8M
NICHD NIH HHS P01 HD080642
6 · The paper itself

Abstract

Primary coenzyme Q

Indexed as

cardiopathyCoenzyme Q10coenzyme Q10 deficiencycoenzyme Q biosynthesisencephalopathynephrotic syndrome

Identifiers

PMID33426503
PMCPMC7791541
OpenAlexW3020079207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.